News | December 15, 2008

MRI No Better in Breast Cancer Staging than Mammography

December 15, 2008 - Breast conserving surgery is not improved by the addition of MRI to other conventional staging assessments, according to a study presented at the San Antonio Breast Cancer Symposium.

Women randomized to receive MRI as part of loco-regional staging before wide local excision were no more likely to avoid mastectomy and or reoperation than those who had the conventional mammogram, ultrasound, and biopsy for staging (P=0.7691), Phil Drew, M.D., of Hull York Medical School in Hull, England.

These findings from the first prospective randomized trial of MRI in this setting confirm the lack of benefit seen in prior retrospective studies, commented Monica Morrow, M.D., of Memorial Sloan-Kettering Cancer Center in New York.

Dr. Morrow recommended a minimal role for MRI in the newly diagnosed patient. As a result, the British National Health Service had Dr. Drew's group assess the new imaging technique in the multicenter, open-label COMICE trial.

The study included 1,623 women with biopsy-proven primary breast cancer who were scheduled for wide local excision based on triple assessment with mammogram, ultrasound, and biopsy. Participants were randomized to additional MR imaging.

At all stages the patients and physicians were informed of the MRI findings, which may have biased the trial results, Dr. Drew said. Although the median size of the index lesion was identical across groups, MR-imaged patients tended to have larger excisions (70.55 versus 63.69 g, P=NS).

For the primary endpoints, the MRI-assessed patients were more likely to go on to have mastectomy instead of the previously planned wide local excision (7.1 percent versus 1.2 percent) with no difference in reoperation rates (18.75 percent versus 19.33 percent, odds ratio 0.96, P=0.7691).

The only significant predictors of reoperation were younger age and lobular cancer, not MRI. MRI had a relatively low effectiveness, and the positive predictive value was 61.8 percent, while the negative predictive value was 83.7 percent.

MRI changed management for 6.1 percent of patients, but 28 percent of multifocal disease was not confirmed pathologically. MRI also correctly detected additional cancerous lesions in 4.8 percent of patients, which was not significant.

Source: San Antonio Breast Cancer Symposium

Source reference: Drew PJ, et al "The UK NIHR multicentre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer" SABCS 2008; Abstract 51.

For more information:

Related Content

Videos | Breast Density | April 26, 2018
ITN Editorial Director Melinda Taschetta-Millane speaks to DenseBreast-info Executive Director JoAnn Pushkin
ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk
News | Breast Imaging | April 06, 2018
New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the...
ACR Recommends More Aggressive Breast Cancer Screening for Higher-Than-Average-Risk Women
News | Breast Imaging | March 29, 2018
The American College of Radiology (ACR) released new breast cancer screening guidelines recommending all women,...
Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Study Finds Women With High Breast Cancer Risk Declining MRI Screening
News | MRI Breast | October 31, 2017
Some women, because of genetic predisposition, personal or family history, have a higher than average lifetime risk of...
Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study
News | MRI Breast | February 10, 2017
February 10, 2017 — A new method for screening women with dense...